Abstract
Angiogenesis is an important biological process in tumor growth and metastasis of tumor cells, and it has been associated with poor clinical outcomes in ovarian cancer. In vitro assays are useful tools for understanding the complex mechanisms of angiogenesis under a variety of conditions. Capillary-like formation and transwell migration assays are two of the most common techniques used in angiogenesis research. Here, we show an easy coculture model to study the role of microRNAs on angiogenesis that combines tube formation and cell migration assays. Recently, we reported that miR-204 is repressed in breast cancer and restoration in cancer cell lines results in angiogenesis inhibition. Here, we restored the expression of miR-204 by transfection of precursor molecule in the tumorigenic SKOV3 ovarian cancer cell line, and analyzed the effects in cell migration, invasion, and tube formation of endothelial cells using matrigel-coated transwell chambers.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M et al (2014) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. doi:10.1002/ijc.29210. PMID:25220842. Published online 9 October 2014
Susana B, Stanley B (2013) New strategies in the treatment of ovarian cancer: current clinical perspectives and future potential. Clin Cancer Res 19:961–968
Jackson AL, Eisenhauer EL, Herzog TJ (2015) Emerging therapies: angiogenesis inhibitors for ovarian cancer. Expert Opin Emerg Drugs 20(2):331–346
Tuija M, Alitalo K (1995) Endothelial receptor tyrosine kinases involved in angiogenesis. J Cell Biol 129:895–898
Wolf-Dietrich C, Fernandez A, Joussen A, Eike-Gert A, Flynn E, Lo KM, Gillies S, Javaherian K, Folkman J, Shing Y (2001) Effect of antiangiogenic therapy on slowly growing, poorly vascularized tumors in mice. J Natl Cancer Inst 93:382–387
Kilarski W, Petersson L, Fuchs PF, Zielinski MS, Gerwins P (2012) An in vivo neovascularization assay for screening regulators of angiogenesis and assessing their effects on pre-existing vessels. Angiogenesis 15:643–655
Holash J, Wiegand SJ, Yancopoulos GD (1999) New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 18:5356–5362
Nishida N, Hirohisa Y, Nishida T, Kamura T, Kojiro M (2006) Angiogenesis in cáncer. Vasc Health Risk Manag 2:213–219
Muthukkaruppan VR, Kubai L, Auerbach R (1982) Tumor-induced neovascularization in the mouse eye. J Natl Cancer Inst 69:699–708
Zhoua Q, Gallaghera R, Ufret-Vincentya R, Lia X, Olsonb E, Wanga S (2011) Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23∼27∼24 clusters. PNAS 108:8287–8292
Wang S, Olson EN (2009) AngiomiRs-key regulators of angiogenesis. Curr Opin Genet Dev 19:205–211
Shaik S, Nucera C, Inuzuka H, Gao D, Garnaas M, Frechette G et al (2012) SCFa-TRCP suppresses angiogenesis and thyroid cancer cell migration by promoting ubiquitination and destruction of VEGF receptor 2. J Exp Med 209:1289–1307
Chen Y, Wei T, Yan L, Lawrence F, Qian H, Burkholder P et al (2008) Developing and applying a gene functional association network for anti-angiogenic kinase inhibitor activity assessment in an angiogenesis co-culture model. BMC Genomics 9:264–273
Carolyn A, Staton MWR, Nicola J, Brown A (2009) Critical analysis of current in vitro and in vivo angiogenesis assays. Int J Exp Path 90:195–221
Martin J, Siemerink IK, Ilse MC, Vogels AW, Griffioen JF, Noorden V, Schlingemann R (2012) CD34 marks angiogenic tip cells in human vascular endothelial cell cultures. Angiogenesis 15:151–163
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Flores-Pérez, A. et al. (2018). Angiogenesis Analysis by In Vitro Coculture Assays in Transwell Chambers in Ovarian Cancer. In: Wu, W. (eds) MicroRNA and Cancer. Methods in Molecular Biology, vol 1699. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7435-1_13
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7435-1_13
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7433-7
Online ISBN: 978-1-4939-7435-1
eBook Packages: Springer Protocols